200,000+ products from a single source!
sales@angenechem.com
CAS No: 203191-10-0 Catalog No: AG0028PR MDL No:
Title | Journal |
---|---|
DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway. | Journal of gastroenterology and hepatology 20120201 |
A mechanism for the action of the compound DA-6034 on NF-κB pathway activation in Helicobacter pylori-infected gastric epithelial cells. | Scandinavian journal of immunology 20110901 |
The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model. | Current eye research 20100201 |
Liquid chromatography-mass spectrometry for the simultaneous determination of the catalpol-related iridoid glucosides, verproside, isovanilloylcatalpol, catalposide and 6-O-veratroyl catalpol in rat plasma. | Biomedical chromatography : BMC 20090901 |
Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601 |
Effects of DA-6034, a flavonoid derivative, on mucin-like glycoprotein and ocular surface integrity in a rabbit model. | Arzneimittel-Forschung 20090101 |
Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis. | International journal of pharmaceutics 20080522 |
DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. | Experimental biology and medicine (Maywood, N.J.) 20080201 |
The effects of DA-6034 on NF-kappaB activity induced by lipopolysaccharide or tumor necrosis factor alpha in a human colonic epithelial cell line. | Hepato-gastroenterology 20080101 |
Gastroprotective effects of DA-6034, a new flavonoid derivative, in various gastric mucosal damage models. | Digestive diseases and sciences 20071101 |
Inhibitory effects of 7-carboxymethyloxy-3',4',5-trimethoxyflavone (DA-6034) on Helicobacter pylori-induced NF-kappa B activation and iNOS expression in AGS cells. | Annals of the New York Academy of Sciences 20070101 |
Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20060301 |
Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats. | Biopharmaceutics & drug disposition 20060101 |
Pharmacokinetics of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (DA-6034), a derivative of flavonoid, in mouse and rat models of chemically-induced inflammatory bowel disease. | The Journal of pharmacy and pharmacology 20060101 |
© 2019 Angene International Limited. All rights Reserved.